Remove Blogging Remove Research Remove San Diego Remove Technology
article thumbnail

San Diego Tech Roundup: Ezoic, Trust & Will, Oska Wellness & More

Xconomy

Summer can be a slow time in San Diego, but its startups have stayed busy. —Ezoic, a startup that developed software for web publishers that uses machine learning techniques to personalize layouts and ad placements for site visitors, raised $33 million to further develop its technology. .

article thumbnail

Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup

Xconomy

San Diego-based Ligand (NASDAQ: LGND ) generates revenue from licensing deals and royalties paid by pharmaceutical companies that use technologies it develops or acquires for their own drug research. The company reported revenues of about $120.3 million in 2019.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UC San Diego Nobel Laureate Roger Tsien Dies at 64

Xconomy

Roger Tsien, a UC San Diego scientist who shared the 2008 Nobel Prize in chemistry for research that led to the development of fluorescent proteins used to illuminate tissue and track biological processes, has died, according to a statement from the university.

article thumbnail

San Diego Sees Strong Cybersecurity Growth As Firms Seek Talent

Xconomy

San Diego’s cybersecurity workforce has grown by nearly 15 percent over the past two years, according to a study released today by the Cyber Center of Excellence, a nonprofit industry group created to boost cybersecurity jobs and technologies in the region. The center also asked the San Diego Regional Economic Development Corp.

article thumbnail

EY Names 6 Startup Leaders as San Diego Entrepreneurs of the Year

Xconomy

Six San Diego business risk-takers have been inducted into the pantheon of EY Entrepreneurs of the Year, joining over 10,000 people around the world who have been honored over the last 30 years by the multinational professional services firm. The winners are: — Life Sciences: BioLegend CEO Gene Lay.

article thumbnail

New San Diego Biotech Looks to Open Way for Anti-Cancer Drugs

Xconomy

He continued his research on tumor vasculature and cancer metastasis. Now 77, Ruoslahti (pictured above) is back in San Diego as a founder and CEO of DrugCendR , a startup developing new ways to improve the uptake of anti-cancer drugs in solid tumors.

article thumbnail

Big VCs Join Xconomy in San Diego to Discuss Big Data, Big Biology

Xconomy

In the Boston office of GE Ventures, managing director Alex de Winter is overseeing investments in companies like Veracyte, which is applying machine learning to genomic sequencing technology to help doctors distinguish benign growths from cancer. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.